Concepedia
Statistics
Publications
41
Citations
3.4K
H-Index
22
Active since
1990
Affiliations
Chiba University(Current)
Nagasaki University
The University of Tokyo
Chiba University Hospital
RIKEN Center for Biosystems Dynamics Research
Naoya Kato is an author at Chiba University specializing in medicine, oncology, and pharmacy.
Publications per year
1990–2025
Correction: Corrigendum: MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma
Kentaro Kojima, Akemi Takata, Charles Vadnais et al. · Nature Communications · 2012 · 1.3K citations · Full text
Medicine, Molecular Biology, Oncology +16
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 466 citations
Medicine, Internal Medicine, Pharmacotherapy +12
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 312 citations · Full text
Medicine, Oncology, Pharmacotherapy +16
Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection
Yue Wang, Naoya Kato, Yujin Hoshida et al. · Hepatology · 2003 · 169 citations · Full text
Life Sciences, Genetics, Molecular Genetics +17
Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction.
Naoya Kato, Osamu Yokosuka, Masao Omata et al. · Journal of Clinical Investigation · 1990 · 157 citations · Full text
Life Sciences, Microbiology, Molecular Biology +14
1–5 of 41